Court dismisses class action suit against Mylan regarding EpiPen
Viatris Inc. on Tuesday announced that a class action lawsuit filed almost four years ago against predecessor company Mylan NV regarding the pricing and marketing of emergency allergy medication EpiPen has been dismissed by a Kansas court.
Viatris (NASDAQ: VTRS) said in a release that the U.S. District Court for the District of Kansas granted Mylan's motion to dismiss in a lawsuit brought against it and Pfizer Inc. by KPH Healthcare Services Inc. on behalf of an asserted class of direct purchasers…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Patty Tascarella Source Type: news
More News: Allergy | Allergy & Immunology | Emergency Medicine | Health Management | Lawsuits | Legislation | Marketing | Pfizer